| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > How to Do Business in China |
|
Main Subject - How to Do Business in China
It is not surprising at all when many foreign investors complained when they do business in China. Many wondered why their years of experience in the business world could not be applied in China immediately. Doing business According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product is about building mutual trust and benefit amidst establishing relationship with people. If you do not understand your counterpart well, it will be quite difficult to establish good cooperation with him/her. An old Chinese ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in saying goes: know yourself and your enemy well and you can fight a hundred battles without any fear of defeat. This greatly emphasized the importance of knowing and understanding your counterpart. Modern economic model dif lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. fer greatly from the traditional one, whereby people in the past ‘fight’ till the last man standing. Today, people seek to achieve a “win-win” situation, and pursue long-term trade cooperation under a fair and healthy compe here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe tition environment. Understanding factors such as China’s history, humanity and culture will be the key to investors’ success in China. As Western thinking and China’s traditional values do differ, encountering the culture d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro differences is therefore inevitable, thus a better understanding of the cultural differences is necessary when doing business in China: 1. Learn how to handle Guanxi (relationship) In China, Guanxi (relationship) is a com ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc plicated field. Establishing relationship with others does not mainly deal with achieving own self-interests or personal goals. A special feature of doing business in China will be that Guanxi (relationship) in China will h easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ave to include relationship with the government body, investors, partners and even relationship with your own staff. China government plays a large role in administrating the investment in China. This is because China is a nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically socialist state; the economy is still largely controlled and managed by the government, so when doing business in China, it is important for foreign investors to learn to coordinate with the China government. At the same ti and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ me, seeking a suitable local partner may be a shortcut and helping hand in developing your business in China market. 2. How to prevail over competition China, at the moment, can be said to be a big, open market, and the a ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ility to prevail over competition is a very important issue today. Investors should fully realize and maximize one's advantages. Some investors are afraid that the China’s imitation products will hurt the sale of their prod ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ucts. Even though this symptom is worrying, however in a free and competitive market, it will always be one that has the superior quality that will not be afraid of competition and will prevail eventually. China market is c dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod onstantly undergoing standardization, and the China government has vowed to protect the quality of the market. The Vice-Minister of the Ministry of Foreign Trade and Economic Cooperation had previously stated in his speech cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin that being a member of the World Trade Organization, China government will continuously rectify and standardize the economic structure of the market, and will persistently crack down illegal acts of producing counterfeit p tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen roducts. Technology level in China is still relatively lagging behind, thus foreign investors should fully make use of their advantages in technology and expertise to produce high-quality products and services. One should n t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ot be over worried about the negative impact brought about by new counterfeited products. Continuous development of one’s technology and emphasizing on innovation will be the key to success. 3. Route for Investment There ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust are three options to take when make investments in China, mainly: wholly foreign-owned enterprise, Chinese-foreign cooperative enterprise and Sino-foreign joint venture. Which option to take will have to depend on factors s y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products uch as the investors' investment direction, investment environment, and the amount of investment to be undertaken. Generally speaking, wholly foreign-owned enterprise require examination and approval from many government bo . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de dies and this process can be quite hassle and time-consuming. Government procedures for establishing Chinese-foreign joint venture and contractual joint ventures will be even more and the process will require even more from elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip more government bodies. Thus Sino-foreign joint venture appears to be the ideal investment option as less governmental procedures and authorization time will be required. Possibility of encountering hiccups will be smaller tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Beta Testing, Anyone? 10 Potent Strategies for Achieving Success Plastic Corrugated and Lean Manufacturing
|